Primary Recipient

SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH

Amount

$99,873.00

Award Date

2/01/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Islet amyloid is a pathological feature of type 2 diabetes and contributes to +?-cell mass loss. It contains the unique peptide islet amyloid polypeptide (IAPP), also known as amylin, and when this peptide aggregates it is toxic to the +?-cell. The purpos